Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

ESPR

+ Watchlist+ Portfolio

Esperion Therapeutics, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
—
52-Week Range
—
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Dividend Yield
—
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
—
Gross Margin
—
Operating Margin
—
Profit Margin
—
Current Ratio
—
Debt/Equity
—
Total Debt
—
Free Cash Flow
—
Revenue Growth
—
Earnings Growth
—
Enterprise Value
—

Market Snapshot

About

Esperion Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing therapies for patients with elevated low-density lipoprotein cholesterol (LDL-C). The company has developed oral non-statin LDL-C lowering medicines for patients who cannot achieve their cholesterol goals with statins alone or who are statin-intolerant. Esperion's commercial products provide additional treatment options for managing cardiovascular risk through lipid modification. The company continues to conduct clinical research to expand approved indications and develop next-generation cardiovascular therapies.